Purple Innovation Q3 2026 earnings

PRPL · 2026-11-04 16:05 AMC ET · 8-K on SEC

Revenue down 18.7% YoY; GAAP loss narrowed to $1.4M; adjusted EBITDA loss of $0.5M; guidance lowered.

Headline numbers

MetricActualYoYQoQ8-K location
Revenue$96.5M-18.7%—Ex. 99.1, income statement
Net income$-1.4M$10.3M improvement—Ex. 99.1, income statement
Adj. EBITDA$-0.5M$0.7M improvement—Ex. 99.1, income statement
Adj. EBITDA margin-0.6%-0.7 pp—Ex. 99.1, income statement

Revenue breakdown

SegmentActualYoYShare of revenueNote
Direct-to-consumer$60.9M-9.4%63%Includes showroom and e-commerce
E-commerce$42.4M-6.5%44%—
Showroom$18.5M-15.9%19%—
Wholesale$35.6M-30.9%37%—

Margins and costs

  • Gross margin 43.4% (prior 47.5%, change -4.1 pp)
  • Operating expenses $51.7M (-24.7% YoY)
  • One-offs in the quarter Restructuring, impairment and other related charges: $1.1M; SGI warrant amortization: $1.8M; Non-operating facility expense: $0.9M
  • Effective tax rate 5.4% (prior-year 0.5%)
  • Non-GAAP bridge Adds back change in fair value of warrant liabilities, stock-based compensation, restructuring, legal fees, strategic alternative costs, severance, impairment, SGI warrant amortization, showroom costs, and non-operating facility expense.

KPIs

MetricActualPrior quarterPrior yearChange
Cash and cash equivalents$28.3M$23.3M$24.3M+$5.0M
Operating cash flow (YTD)$10.6M$3.6M$-27.1M+$37.7M
Showroom count5755—+2

Guidance

MetricGuidePrior guideChange
Revenue$420M - $440M$420M - $440MNo change
Adjusted EBITDA$15M - $20M$20M - $25M-$5M to -$5M

What drove it

  • Revenue story Wholesale down 30.9% to $35.6M; DTC down 9.4% to $60.9M; e-commerce down 6.5% to $42.4M; showroom down 15.9% to $18.5M.
  • EPS story GAAP loss per share improved to -$0.33 from -$2.71 YoY; adjusted loss per share widened to -$2.41 from -$1.99 YoY.
  • One-off check Restructuring, impairment and other related charges: $1.1M; SGI warrant amortization: $1.8M; Non-operating facility expense: $0.9M.

The good

  • GAAP net loss narrowed to $1.4M
  • Operating cash flow positive for third consecutive quarter
  • Cash and cash equivalents increased to $28.3M

The bad

  • Revenue down 18.7% YoY
  • Adjusted EBITDA loss of $0.5M
  • Gross margin down 4.1 pp YoY to 43.4%

The ugly

  • Wholesale revenue down 30.9% YoY
  • Adjusted EBITDA guidance cut by $5M to $15M-$20M

Open questions

  • Why did adjusted EBITDA turn to a loss despite cost cuts?
  • What specific actions are being taken to improve wholesale performance?
Full release

Purple Innovation (PRPL) earnings release, November 4, 2026

Purple Innovation, Inc. (PRPL) · Form 8-K, Item 2.02 · Filed · SEC filing

CONFIDENTIAL DRAFT

Purple Innovation Reports Third Quarter 2026

Results

Positive Operating Cash Flow for the Third Consecutive

Quarter

Preparing for Major Mattress Portfolio Refresh to Strengthen Performance in 2027

Lehi, Utah, November 4, 2026 – Purple Innovation, Inc. (NASDAQ:

PRPL) (“Purple”), a comfort innovation company whose mattresses promise to give you “less pain, better sleep,” today announced results for the third quarter ended September 30, 2026.

“Third quarter performance was mixed as we continued to navigate a challenging mattress environment,” said Rob DeMartini, CEO of Purple Innovation. “We were encouraged by improving momentum in our e-commerce business as the quarter progressed, supported by stronger conversion rates on Purple.com, and we opened two new showrooms during the quarter, bringing our network to 57 stores. Wholesale was not where we needed it to be, and we have begun increasing sales coverage and improving how we position and differentiate our products with retail partners.”

“We have taken steps to improve our cost structure, and are consistently generating cash, with positive operating cash flow for the third consecutive quarter. At the same time, we are actively preparing for a significant product refresh planned for early 2027, including new Essentials and Hybrid collections representing almost 90% of our mattress unit volume. Our teams are focused on ensuring we are well positioned for a successful launch and believe these initiatives position us to strengthen our performance over the long term.”

Third Quarter 2026 Financial Results

Third quarter 2026 net revenue was $96.5 million, down 18.7% compared with $118.8 million in the third quarter of 2025. The decrease was primarily driven by lower wholesale revenue, along with declines in showroom and e-commerce revenue.

Direct-to-consumer revenue, which includes e-commerce and showroom channels, was $60.9 million compared with $67.2 million in the prior year period. E-commerce revenue was $42.4 million versus $45.3 million last year. Showroom revenue was $18.5 million versus $22.0 million last year. Wholesale revenue was $35.6 million versus $51.5 million.

Approximately one quarter of the reduction was due to an increase of $4.0 million in reductions of revenue due to certain payments to customers and a manufacturer under common control with a customer.

Gross margin was 43.4%, a decrease of 410 basis points versus last year. The decline reflected lower production leverage and inventory adjustments partially offset by lower tariff costs and favorable channel mix.

Third quarter operating expenses were $51.7 million, down 24.7% from the prior-year quarter. The improvement reflected lower restructuring costs versus the prior period as well as lower marketing expenses, and employee-related and professional services expenses.

GAAP Net Loss for the third quarter was $1.4 million, compared with a GAAP Net Loss of $11.7 million in the prior-year period.

Adjusted EBITDA for the third quarter was a loss of $0.5 million, compared with adjusted EBITDA of $0.2 million in the prior-year period. Adjusted EBITDA is a non-GAAP financial measure. See discussion under the heading “Non-GAAP Financial Measures” below for additional information.

Balance Sheet

The Company ended the third quarter with cash and cash equivalents of $28.3 million, compared with $24.3 million as of December 31, 2025. Cash flow from operating activities YTD as of September 30, 2026 was $10.6 million, a $38.7 million improvement over the prior year’s same period.

Net inventories as of September 30, 2026, totaled $53.5 million, down

$6.2 million from December 31, 2025.

2026 Outlook

We are maintaining our revenue guidance in the range of $420 million to $440 million, supported by an improved marketing plan, normal seasonal strength in DTC, and new product introductions, partially offset by continued pressure in wholesale. Adjusted EBITDA is now expected to be in the range of $15 million and $20 million.

Conference Call and Webcast Information

Purple Innovation, Inc. will host a live conference call to discuss financial results on November 4, 2026, at 4:30 pm Eastern Time. Investors and analysts interested in participating in the call are invited to dial 833-461-5787 (domestic) or 585-542-9983 (international) and enter Conference ID 735 896 138. The conference call will also be available through a live webcast on the investor relations section of the Company’s website at investors.purple.com. Please visit the website at least 15 minutes prior to the start of the call to register and download any necessary software. After the conference call, a webcast replay will remain available on the investor relations section of the Company’s website for one year.

About Purple

Purple exists to help people get the best sleep of their lives — by reducing pain, deepening sleep, and unlocking the potential for brighter dawns and better days. At the center of that mission is our signature innovation, the GelFlex Grid®. Originally developed in medical settings to support the body in its most vulnerable moments, the GelFlex Grid delivers a one-of-a-kind combination of pressure relief, alignment, and temperature balance that helps people fall asleep easier, stay asleep longer, and wake up with less pain.

That same comfort technology extends beyond mattresses into pillows, bedding, and cushions designed to make everyday life feel a little lighter and a lot more comfortable. Because when pain eases and sleep improves, everything else gets better too — your energy, your outlook, and your ability to show up for the moments that matter.

Less pain. Better sleep.

Learn more at www.purple.com²

Forward Looking Statements

Certain statements made in this release that are not historical facts... (truncated)eaning of the “safe harbor” provisions of the United States Private

Financial statements

Income Statement

Three Months Ended September 30, — (unaudited – in thousands, except per share amounts)

Three Months Ended September 30, – 2026Three Months Ended September 30, – 2025Nine Months Ended September 30, – 2026Nine Months Ended September 30, – 2025
Revenues, net96,506118,766290,506328,037
Cost of revenues:
Cost of revenues54,58262,273163,948182,374
Cost of revenues - restructuring related charges995
Total cost of revenues54,58262,273163,948183,369
Gross profit41,92456,493126,558144,668
Operating expenses:
Marketing and sales36,27345,762106,589122,450
General and administrative11,96315,20042,44144,678
Research and development2,3582,3677,2916,997
Restructuring, impairment and other related charges1,1015,2901,10111,387
Total operating expenses51,69568,619157,422185,512
Operating loss-9,771-12,126-30,864-40,844
Other income (expense):
Interest expense-8,090-8,203-24,121-20,424
Other income, net2,2021,7425,1481,812
Change in fair value – warrant liabilities14,3156,89214,75011,319
Total other income (expense), net8,427431-4,223-7,293
Net loss before income taxes-1,344-11,695-35,087-48,137
Income tax expense-76-53-155-148
Net loss-1,420-11,748-35,242-48,285
Net loss attributable to noncontrolling interest-22-28-73-83
Net loss attributable to Purple Innovation, Inc.-1,398-11,720-35,169-48,202
Net loss per share:
Basic-0.32-2.71-8.09-11.16
Diluted-0.33-2.71-8.09-11.16
Weighted average common shares outstanding:
Basic4,3534,3304,3474,321
Diluted4,3604,3374,3544,328

Income Statement

Three Months Ended September 30,

Three Months Ended September 30, – 2026Three Months Ended September 30, – 2025Nine Months Ended September 30, – 2026Nine Months Ended September 30, – 2025
GAAP net loss-1,420-11,748-35,242-48,285
Interest expense8,0908,20324,12120,424
Income tax expense7653155148
Other income, net-987-1,742-1,502-1,812
Depreciation and amortization4,4649,77713,35219,658
EBITDA10,2234,543884-9,867
Adjustments:
Change in fair value - warrant liability-14,315-6,892-14,750-11,320
Stock-based compensation expense49420-1721.265
Restructuring related charges656,850
Non-recurring legal fees423102311,450
Strategic alternative costs5266985,5561,958
Severance costs822,0581,652
Impairment1,1011,101
SGI warrant amortization1,8381,838
Showroom opening and closing costs147
Non-operating facility expense964964
Adjusted EBITDA-536190-3,254-6,901

Income Statement

Three Months Ended September 30, (in thousands, except per share amounts)

Three Months Ended September 30, – 2026Three Months Ended September 30, – 2025Nine Months Ended September 30, – 2026Nine Months Ended September 30, – 2025
Net loss-1,420-11,748-35,242-48,285
Income tax expense, as reported7653155148
Revenue reduction due to SGI contract9419412,8221,568
Change in fair value – warrant liabilities-14,315-6,892-14,750-11,319
Restructuring related charges5,29012,382
Strategic alternative costs5266985,5561,958
Adjusted net loss before income taxes-14,192-11,658-41,459-43,548
Adjusted income tax benefit(1)3,6763,02610,73811,279
Adjusted net loss-10,516-8,632-30,721-32,269
Adjusted net loss per share, diluted-2.41-1.99-7.06-7.46
Adjusted weighted-average shares outstanding, diluted(2)4,3604,3374,3544,328

Income Statement

For the Three Months Ended (in thousands, except per share amounts)

For the Three Months Ended – September 30, 2026 – Net LossFor the Three Months Ended – September 30, 2026 – Weighted Average Shares, DilutedFor the Three Months Ended – September 30, 2026 – Net Loss per Share, DilutedFor the Three Months Ended – September 30, 2025 – Net LossFor the Three Months Ended – September 30, 2025 – Weighted Average Shares, DilutedFor the Three Months Ended – September 30, 2025 – Net Loss per Share, Diluted
Net loss attributable to Purple Innovation Inc.(1)-1,3984,360-0.33-11,7204,337-2.71
Assumed exchange of shares(2)-22-28
Net loss-1,420-11,748
Adjustments to arrive at adjusted loss before taxes(3)-12,77290
Adjusted loss before taxes-14,192-11,658
Adjusted income tax benefit(4)3,6763,026
Adjusted net loss-10,5164,360-2.41-8,6324,337-1.99

Balance Sheet

September 30, 2026 — (unaudited – in thousands, except for par value)

September 30, 2026December 31, 2025
Current assets:
Cash and cash equivalents28,34424,345
Accounts receivable, net11,55041,272
Inventories53,49759,725
Prepaid expenses4,7155,487
Other current assets4,9015,891
Total current assets103,007136,720
Property and equipment, net71,59977,961
Operating lease right-of-use assets63,65167,271
Intangible assets, net5,5946,346
Other long-term assets4,4267,961
Total assets248,277296,259
Current liabilities:
Accounts payable39,72040,312
Accrued compensation3,4917,673
Customer prepayments3,5615,276
Accrued rebates and allowances6,14513,416
Accrued warranty liabilities – current portion7,9577,141
Operating lease obligations – current portion16,07517,366
Related party debt – current portion135,083
Other current liabilities8,53010,339
Total current liabilities220,562101,523
Related party debt, net of current portion111,305
Accrued warranty liabilities, net of current portion18,55619,570
Operating lease obligations, net of current portion71,30475,616
Warrant liabilities1,40016,150
Other long-term liabilities1,6261,764
Total liabilities313,448325,928
Stockholders’ equity (deficit):
Additional paid-in capital595,301595,593
Accumulated deficit-660,449-625,280
Total stockholders’ deficit attributable to Purple Innovation, Inc.-65,148-29,687
Noncontrolling interest-2318
Total stockholders’ deficit-65,171-29,669
Total liabilities and stockholders’ deficit248,277296,259

Cash Flow

Nine Months Ended September 30, — (unaudited – in thousands)

Nine Months Ended September 30, – 2026Nine Months Ended September 30, – 2025
Cash flows from operating activities:
Net loss-35,242-48,285
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization13,35219,659
Non-cash interest9,8929,537
Paid-in-kind interest14,23211,266
Non-cash restructuring, impairment and other related charges1,1013,775
Loss on disposal of property and equipment154318
Change in fair value – warrant liabilities-14,750-11,319
Stock-based compensation-1721,265
Changes in operating assets and liabilities:
Accounts receivable29,7227,847
Inventories6,228-8,907
Prepaid expenses and other assets4,949755
Operating leases, net-2,865-2,080
Accounts payable-514-4,464
Accrued compensation-4,182-1,650
Customer prepayments-1,715-1,202
Accrued rebates and allowances-7,271307
Accrued warranty liabilities-198-407
Other accrued liabilities-2,083-4,445
Net cash provided by (used in) operating activities10,638-28,030
Cash flows from investing activities:
Sale of property and equipment464
Purchase of property and equipment-5,217-6,076
Investment in intangible assets-1,076-454
Net cash used in investing activities-6,293-6,066
Cash flows from financing activities:
Proceeds from related party loan39,000
Payments for debt issuance costs-346-1,557
Net cash (used in) provided by financing activities-34637,443
Net increase in cash and cash equivalents3,9993,347
Cash and cash equivalents, beginning of the period24,34529,011
Cash and cash equivalents, end of the period28,34432,358

Securities Litigation Reform Act of 1995. Statements based on historical data are not intended and should not be understood to indicate the Company’s expectations regarding future events. Forward-looking statements provide current expectations or forecasts of future events or determinations. These statements include, but are not limited to, statements regarding our innovation pipeline, our ability to improve profitability, manage costs, generate cash, and optimize our business, the expansion of and benefits to us from our commercial relationships, our ability to drive profitable growth and create shareholder value, and our outlook for revenue and adjusted EBITDA for the full year 2026, our ability to manage upcoming debt maturities, the timing, scope, and anticipated benefits of new product launches, and potential strategic transactions. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside the

Company’s control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. Factors that could influence the realization of forward-looking statements include, among others: changes in economic, financial and end-market conditions in the markets in which we operate; fluctuations in raw material prices and cost of labor; the financial condition of our customers and suppliers; competitive pressures, including the need for technology improvement, successful new product development and introduction; changes in consumer demand, including pullbacks in consumer spending; disruptions to our manufacturing processes; and the risk factors outlined in the “Risk Factors” section of our Annual Report on Form 10-K filed with the Securities and Exchange

Commission on March 31, 2026, and in our other filings made with the SEC. The Company does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Non-GAAP Financial Measures

EBITDA, adjusted EBITDA, adjusted net loss, and adjusted net loss per diluted share are non-GAAP financial measures that remove the impact of certain non-cash and non-recurring costs. Management believes that the use of such non-GAAP financial measures provides investors with additional useful information with respect to the impact of various adjustments, which we view as a better measure of our operating performance. Refer to the attached table for the reconciliation of such non-GAAP financial measures to the most comparable GAAP financial measure.

With respect to the Company’s adjusted EBITDA outlook for the full year 2026, a quantitative reconciliation to the corresponding GAAP information cannot be provided without unreasonable effort because of the inherent difficulty of accurately forecasting the occurrence and financial impact of the various adjusting items necessary for such reconciliation that have not yet occurred, are out of our control, or cannot be reasonably predicted, including but not limited to warrant liabilities and stock-based compensation. For the same reasons, the Company is unable to assess the probable significance of the unavailable information, which could have a material impact on its future GAAP financial results.

Investor Contact:

Stacy Turnof, Edelman Smithfield stacy.turnof@edelmansmithfield.com

917-362-2581³

PURPLE INNOVATION, INC.

Condensed Consolidated Balance Sheets

(unaudited – in thousands, except for par value)⁴

PURPLE INNOVATION, INC.

Condensed Consolidated Statements of Operations

(unaudited – in thousands, except per share amounts)⁵

PURPLE INNOVATION, INC.

Condensed Consolidated Statements of Cash Flows

(unaudited – in thousands)⁶

PURPLE INNOVATION, INC.

RECONCILIATION OF GAAP TO NON-GAAP MEASURES

(In thousands)

Management believes that the use of the following non-GAAP financial measures provides investors with additional useful information with respect to the impact of various adjustments, which we view as a better measure of our operating performance. These non-GAAP financial measures are EBITDA, adjusted EBITDA, adjusted net loss and adjusted net loss per diluted share. Other companies may calculate these non-GAAP measures differently than we do. These non-GAAP measures have limitations as analytical tools, and you should not consider them in isolation or as a substitute for our financial results prepared in accordance with GAAP.

Reconciliation of GAAP Net Income (Loss) to

Non-GAAP EBITDA and Adjusted EBITDA

A reconciliation of GAAP net income (loss) to the non-GAAP measures of EBITDA and adjusted EBITDA is provided below. EBITDA represents net loss before interest expense, income tax expense, other income, net, and depreciation and amortization. Adjusted EBITDA represents EBITDA excluding costs incurred due to changes in the fair value of the warrant liability, stock-based compensation expense, restructuring related charges, non-recurring legal fees, strategic alternative costs, severance cost, impairment, SGI warrant amortization, showroom opening and closing costs and non-operating facility expense. We believe EBITDA and Adjusted EBITDA provide additional useful information with respect to the impact of various adjustments and provide meaningful measures of our operating performance.⁷

Reconciliation of GAAP Net Loss to non-GAAP Adjusted Net Loss and

Adjusted Net Loss per Diluted Share

Our presentation of adjusted net loss assumes that all net loss is attributable to Purple Innovation, Inc. (i.e. there is no allocation of net loss to noncontrolling interests), which... (truhe full exchange at the beginning of the period of all outstanding Paired Securities for shares of Class A common stock of Purple

Innovation, Inc., adjusted for certain nonrecurring items that we do not believe directly reflect our core operations. Adjusted net loss per share, diluted, is calculated by dividing adjusted net loss by the total shares of Class A common stock outstanding plus any dilutive warrants, options and restricted stock as calculated in accordance with GAAP and assuming the full exchange of all outstanding Paired

Securities as of the beginning of each period presented. Adjusted net loss and adjusted net loss per diluted share, are supplemental measures of operating performance that do not represent, and should not be considered, alternatives to net loss and earnings per share, as calculated in accordance with GAAP. We believe adjusted net loss and adjusted net loss per diluted share, supplement GAAP measures and enable us to more effectively evaluate our performance period-over-period. A reconciliation of net loss, the most directly comparable GAAP measure, to adjusted net loss and the computation of adjusted net loss per diluted share, are set forth below:⁸

A reconciliation of net loss per share, diluted, to adjusted net loss per share, diluted is set forth below for the three months ended September 30, 2026 and 2025:⁹

A reconciliation of net loss per share, diluted, to adjusted net loss per share, diluted is set forth below for the nine months ended September 30, 2026 and 2025:¹⁰

Earlier releases

From SEC EDGAR. Analysis by Pear Digitals from the filing alone. Not investment advice. · Latest earnings · Markdown

Screener

Plans

Premium and Pro coming soon.

Log in

New here?

Join the waitlist

Pear FMV opens to everyone soon. We'll email you when it does.